Select a dose to see the cheapest documented option that covers it. Providers with verified same-price-across-dose terms are included automatically at every applicable dose; there is no separate flat-price selection. Flat-rate and variable dose-tier providers compete together, with verified required fees included. Comparable monthly, 28-day, 30-day, and four-week injection supplies retain their actual billing labels; no monthly equivalent is invented. Unmatched offers remain visible but unranked. Dose tiers are catalog information, not dosing advice.
Adonix Blend — Listed by provider · $200/mo total · Single weekly injection combining MOTS-C, AOD-9604, tesamorelin, and ipamorelin; 400 units per month.Headline price source
Product type
Compounded product listing
Subscription
No separate subscription
Available dosage / strength
Weekly at-home subcutaneous MOTS-C injection kit with vial or vials, syringes, swabs, and instructions. Conflicting image metadata prevents treating the pictured 5 mL / 10 mg as a verified structured strength.; 12-month recurring plan ($182); 6-month recurring plan ($193); 3-month recurring plan ($206); Article six-month plan — first month ($146); Article six-month plan — thereafter ($196); Article three-month plan — first month ($166); Article three-month plan — thereafter ($216); Article monthly plan — first month ($216)
AOD - 9604/MOTs-C — Listed by provider · $465 per 28-day package · subcutaneous injection; 6 current direct-table plan rows. Provider review, prescribed medication, pharmacy fulfillment, applicable supplies, tracked shipping and follow-up are included without a separate public membership or consult fee.Headline price source
AOD - 9604/MOTs-C/Tesamorelin — Listed by provider · $545 per 28-day package · subcutaneous injection; 6 current direct-table plan rows. Provider review, prescribed medication, pharmacy fulfillment, applicable supplies, tracked shipping and follow-up are included without a separate public membership or consult fee.Headline price source
Product type
Compounded product listing
Subscription
No separate subscription
Available dosage / strength
subcutaneous injection; 7 current direct-table plan rows. Provider review, prescribed medication, pharmacy fulfillment, applicable supplies, tracked shipping and follow-up are included without a separate public membership or consult fee.; 0.4mg SQ daily for 4 Weeks ($445); 0.5mg SQ daily for 4 Weeks ($445); 0.6mg SQ daily for 4 Weeks ($445); 0.7mg SQ daily for 4 Weeks ($595); 0.8mg SQ daily for 4 Weeks ($595); 0.9mg SQ daily for 4 Weeks ($595); 1mg SQ daily for 4 Weeks ($595)
MOTS-c professional telehealth service tiers at 10 and 50 mg. Professional telehealth service only. Medication is not included; if prescribed, it is billed separately by the pharmacy. LeadWest Medical does not sell or ship medications.; 10 mg (10 mg dose, $220); 50 mg (50 mg dose, $685)
Current Recess Rx managed-medication identity; exact route, strength, concentration, package, prescribed duration, pharmacy, and medication amount are not public.
MOTS-C 10mg/ml (5ml) — Listed; checkout not currently open · Exact current anonymous-store package: MOTS-C 10mg/ml (5ml).Product source
MOTS-C 2mg/ml (5ml) — Listed; checkout not currently open · Exact current anonymous-store package: MOTS-C 2mg/ml (5ml).Product source
MOTS-C 2mg/ml Injectable (Pre-mixed) (5ml) — Listed; checkout not currently open · Exact current anonymous-store package: MOTS-C 2mg/ml Injectable (Pre-mixed) (5ml). The exact administration route is not inferred from package nomenclature alone.Product source
Product type
Product type unclear
Subscription
No separate subscription
Available dosage / strength
Exact current anonymous-store package: MOTS-c / Tesamorelin (2mg/3mg/mL), 5ml.
Adonix Blend — Listed by provider · $200/mo total · Single weekly injection combining MOTS-C, AOD-9604, tesamorelin, and ipamorelin; 400 units per month.Headline price source
Compounded product listing
No separate subscription
Weekly at-home subcutaneous MOTS-C injection kit with vial or vials, syringes, swabs, and instructions. Conflicting image metadata prevents treating the pictured 5 mL / 10 mg as a verified structured strength.; 12-month recurring plan ($182); 6-month recurring plan ($193); 3-month recurring plan ($206); Article six-month plan — first month ($146); Article six-month plan — thereafter ($196); Article three-month plan — first month ($166); Article three-month plan — thereafter ($216); Article monthly plan — first month ($216)
AOD - 9604/MOTs-C — Listed by provider · $465 per 28-day package · subcutaneous injection; 6 current direct-table plan rows. Provider review, prescribed medication, pharmacy fulfillment, applicable supplies, tracked shipping and follow-up are included without a separate public membership or consult fee.Headline price source
AOD - 9604/MOTs-C/Tesamorelin — Listed by provider · $545 per 28-day package · subcutaneous injection; 6 current direct-table plan rows. Provider review, prescribed medication, pharmacy fulfillment, applicable supplies, tracked shipping and follow-up are included without a separate public membership or consult fee.Headline price source
Compounded product listing
No separate subscription
subcutaneous injection; 7 current direct-table plan rows. Provider review, prescribed medication, pharmacy fulfillment, applicable supplies, tracked shipping and follow-up are included without a separate public membership or consult fee.; 0.4mg SQ daily for 4 Weeks ($445); 0.5mg SQ daily for 4 Weeks ($445); 0.6mg SQ daily for 4 Weeks ($445); 0.7mg SQ daily for 4 Weeks ($595); 0.8mg SQ daily for 4 Weeks ($595); 0.9mg SQ daily for 4 Weeks ($595); 1mg SQ daily for 4 Weeks ($595)
MOTS-c professional telehealth service tiers at 10 and 50 mg. Professional telehealth service only. Medication is not included; if prescribed, it is billed separately by the pharmacy. LeadWest Medical does not sell or ship medications.; 10 mg (10 mg dose, $220); 50 mg (50 mg dose, $685)
Current Recess Rx managed-medication identity; exact route, strength, concentration, package, prescribed duration, pharmacy, and medication amount are not public.
MOTS-C 10mg/ml (5ml) — Listed; checkout not currently open · Exact current anonymous-store package: MOTS-C 10mg/ml (5ml).Product source
MOTS-C 2mg/ml (5ml) — Listed; checkout not currently open · Exact current anonymous-store package: MOTS-C 2mg/ml (5ml).Product source
MOTS-C 2mg/ml Injectable (Pre-mixed) (5ml) — Listed; checkout not currently open · Exact current anonymous-store package: MOTS-C 2mg/ml Injectable (Pre-mixed) (5ml). The exact administration route is not inferred from package nomenclature alone.Product source
Product type unclear
No separate subscription
Exact current anonymous-store package: MOTS-c / Tesamorelin (2mg/3mg/mL), 5ml.
Daily injectable MOTS-C peptide; dose varies with provider-directed use.
Video or phone visit
No FDA-approved productSources checked Aug 14, 2026
Regulatory and pricing context
No FDA-approved MOTS-c product exists. A July 2026 advisory vote was nonbinding and did not itself approve a product or change federal compounding rules. Context source
Displayed prices and dose options are provider-stated snapshots. They may vary by dose, formulation, shipping, state, eligibility, insurance, commitment length, and required subscription. “Not listed” means the reviewed public source did not provide a value.
Information only; not medical advice, a safety evaluation, or a provider endorsement.
Research-use-only suppliers are separate. Their catalog prices never enter the prescription-provider comparison above.